Retraction notice to “The endocannabinoid signaling pathway as an emerging target in pharmacotherapy, earmarking mitigation of destructive events in rheumatoid arthritis” [Life Sci. 257 (2020) 118109] (Life Sciences (2020) 257, (S0024320520308602), (10.1016/j.lfs.2020.118109))

This article has been retracted: please see Elsevier policy on Article Correction, Retraction and Removal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. The authors have plagiarised portions of papers that had already appeared in:Life Sciences, 204 (2018), p. 20–45. https://doi.org/10.1016/j.lfs.2018.04.054 The Lancet, 388 (2016), p. 2023–2038. https://doi.org/10.1016/S0140-6736(16)30173-8 European Journal of Rheumatology, 4 (2017), p. 210–218. https://doi.org/10.5152/eurjrheum.2017.17025.One of the conditions of submission of a paper for publication is that authors declare explicitly that their work is original and has not appeared in a publication elsewhere. Re-use of any data should be appropriately cited. As such this article represents a severe abuse of the scientific publishing system. The scientific community takes a very strong view on this matter and apologies are offered to readers of the journal that this was not detected during the submission process.